Literature DB >> 31971600

Pustular Psoriasis: The Dawn of a New Era.

Hervez Bachelez1.   

Abstract

Pustular psoriasis is a clinically heterogeneous entity of different, orphan disease subtypes, among which the most clearly defined are generalized pustular psoriasis, palmoplantar psoriasis, and acrodermatitis continua of Hallopeau. Although phenotypically and genetically distinct from psoriasis vulgaris, these subtypes may be associated with plaque psoriasis lesions, establishing the rationale for their inclusion in the psoriasis spectrum. Unlike psoriasis, however, their genetic background is thought to be mainly monogenic, as shown by the recent identification of mutations in 3 different genes of the skin innate immune system; IL36RN, CARD14 and AP1S3. These major advances in the understanding of the disease pathogenesis have led to the design and ongoing development of tailored therapeutic approaches, which are highly necessary given the refractory nature of pustular psoriasis in response to most available antipsoriatic drugs.

Entities:  

Keywords:  generalized pustular psoriasis; interleukin-36; palmoplantar pustulosis; pustular psoriasis; pustulosis

Mesh:

Substances:

Year:  2020        PMID: 31971600      PMCID: PMC9128889          DOI: 10.2340/00015555-3388

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  58 in total

1.  Successful treatment of generalized pustular psoriasis with the interleukin-1-receptor antagonist Anakinra: lack of correlation with IL1RN mutations.

Authors:  Manuelle Viguier; Philippe Guigue; Cécile Pagès; Asma Smahi; Hervé Bachelez
Journal:  Ann Intern Med       Date:  2010-07-06       Impact factor: 25.391

2.  Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis.

Authors:  Alexandros Onoufriadis; Michael A Simpson; Andrew E Pink; Paola Di Meglio; Catherine H Smith; Venu Pullabhatla; Jo Knight; Sarah L Spain; Frank O Nestle; A David Burden; Francesca Capon; Richard C Trembath; Jonathan N Barker
Journal:  Am J Hum Genet       Date:  2011-08-11       Impact factor: 11.025

3.  Successful therapy with anakinra in a patient with generalized pustular psoriasis carrying IL36RN mutations.

Authors:  U Hüffmeier; M Wätzold; J Mohr; M P Schön; R Mössner
Journal:  Br J Dermatol       Date:  2014-01       Impact factor: 9.302

Review 4.  Psoriasis.

Authors:  Frank O Nestle; Daniel H Kaplan; Jonathan Barker
Journal:  N Engl J Med       Date:  2009-07-30       Impact factor: 91.245

5.  Palmoplantar Pustular Psoriasis Is Associated with Missense Variants in CARD14, but Not with Loss-of-Function Mutations in IL36RN in European Patients.

Authors:  Rotraut Mössner; Yvonne Frambach; Dagmar Wilsmann-Theis; Sabine Löhr; Arnd Jacobi; Ansgar Weyergraf; Michael Müller; Sandra Philipp; Regina Renner; Heiko Traupe; Harald Burkhardt; Külli Kingo; Sulev Kõks; Steffen Uebe; Michael Sticherling; Heinrich Sticht; Vinzenz Oji; Ulrike Hüffmeier
Journal:  J Invest Dermatol       Date:  2015-05-19       Impact factor: 8.551

Review 6.  European consensus statement on phenotypes of pustular psoriasis.

Authors:  A A Navarini; A D Burden; F Capon; U Mrowietz; L Puig; S Köks; K Kingo; C Smith; J N Barker
Journal:  J Eur Acad Dermatol Venereol       Date:  2017-08-29       Impact factor: 6.166

7.  An autoinflammatory disease due to homozygous deletion of the IL1RN locus.

Authors:  Sreelatha Reddy; Shuang Jia; Rhonda Geoffrey; Rachel Lorier; Mariko Suchi; Ulrich Broeckel; Martin J Hessner; James Verbsky
Journal:  N Engl J Med       Date:  2009-06-04       Impact factor: 91.245

Review 8.  The clinical spectrum of psoriasis.

Authors:  Luigi Naldi; Daniele Gambini
Journal:  Clin Dermatol       Date:  2007 Nov-Dec       Impact factor: 3.541

9.  Generalized pustular psoriasis. A review of 63 cases.

Authors:  B D Zelickson; S A Muller
Journal:  Arch Dermatol       Date:  1991-09

10.  Guselkumab, a human interleukin-23 monoclonal antibody in Japanese patients with generalized pustular psoriasis and erythrodermic psoriasis: Efficacy and safety analyses of a 52-week, phase 3, multicenter, open-label study.

Authors:  Shigetoshi Sano; Hiroshi Kubo; Hitomi Morishima; Ryosuke Goto; Richuan Zheng; Hidemi Nakagawa
Journal:  J Dermatol       Date:  2018-03-22       Impact factor: 4.005

View more
  7 in total

1.  CARD14E138A signalling in keratinocytes induces TNF-dependent skin and systemic inflammation.

Authors:  Joan Manils; Louise V Webb; Ashleigh Howes; Julia Janzen; Stefan Boeing; Anne M Bowcock; Steven C Ley
Journal:  Elife       Date:  2020-06-29       Impact factor: 8.713

2.  Study protocol of the global Effisayil 1 Phase II, multicentre, randomised, double-blind, placebo-controlled trial of spesolimab in patients with generalized pustular psoriasis presenting with an acute flare.

Authors:  Siew Eng Choon; Mark G Lebwohl; Slaheddine Marrakchi; A David Burden; Tsen-Fang Tsai; Akimichi Morita; Alexander A Navarini; Min Zheng; Jinhua Xu; Hamida Turki; Sushmita Rajeswari; Hongjie Deng; Kay Tetzlaff; Christian Thoma; Hervé Bachelez
Journal:  BMJ Open       Date:  2021-03-30       Impact factor: 2.692

Review 3.  Pustular Psoriasis: A Narrative Review of Recent Developments in Pathophysiology and Therapeutic Options.

Authors:  Alan Menter; Abby S Van Voorhees; Sylvia Hsu
Journal:  Dermatol Ther (Heidelb)       Date:  2021-10-09

Review 4.  Treatment Options and Goals for Patients with Generalized Pustular Psoriasis.

Authors:  James Krueger; Lluís Puig; Diamant Thaçi
Journal:  Am J Clin Dermatol       Date:  2022-01-21       Impact factor: 7.403

Review 5.  Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond.

Authors:  Kazumitsu Sugiura
Journal:  Dermatol Ther (Heidelb)       Date:  2022-01-21

Review 6.  Pustular Psoriasis: From Pathophysiology to Treatment.

Authors:  Giovanni Genovese; Chiara Moltrasio; Nicoletta Cassano; Carlo Alberto Maronese; Gino Antonio Vena; Angelo Valerio Marzano
Journal:  Biomedicines       Date:  2021-11-23

7.  Patient characteristics and burden of disease in Japanese patients with generalized pustular psoriasis: Results from the Medical Data Vision claims database.

Authors:  Akimichi Morita; Nirali Kotowsky; Ran Gao; Reiko Shimizu; Yukari Okubo
Journal:  J Dermatol       Date:  2021-07-01       Impact factor: 3.468

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.